Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Genedx Holdings Corp (WGS)
Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,414
  • Shares Outstanding, K 25,884
  • Annual Sales, $ 234,690 K
  • Annual Income, $ -548,980 K
  • 60-Month Beta 1.90
  • Price/Sales 0.18
  • Price/Cash Flow N/A
  • Price/Book 0.18
Trade WGS with:

Options Overview Details

View History
  • Implied Volatility 170.92% ( -61.44%)
  • Historical Volatility 145.56%
  • IV Percentile 52%
  • IV Rank 11.77%
  • IV High 1,260.23% on 01/18/23
  • IV Low 25.63% on 01/17/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 30
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 11,616
  • Open Int (30-Day) 11,569

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.70
  • Number of Estimates 1
  • High Estimate -0.70
  • Low Estimate -0.70
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1600 +29.31%
on 11/16/23
2.4200 -38.02%
on 11/24/23
-0.0700 (-4.46%)
since 11/07/23
3-Month
1.1600 +29.31%
on 11/16/23
5.1300 -70.76%
on 09/12/23
-2.9100 (-65.99%)
since 09/07/23
52-Week
1.1600 +29.31%
on 11/16/23
17.9091 -91.62%
on 02/16/23
-7.9776 (-84.17%)
since 12/07/22

Most Recent Stories

More News
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

/PRNewswire/ -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in...

PACB : 8.38 (-1.41%)
WGS : 1.5000 (-6.25%)
Why GeneDx Holdings Stock Lagged the Market Today

A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.

WGS : 1.5000 (-6.25%)
NDAQ : 54.13 (-3.06%)
Elevance (ELV) to Divest Life & Disability Business to StanCorp

With the sale of the life and disability business, Elevance Health (ELV) is focusing on growing its more profitable operations.

ICLR : 268.19 (-0.09%)
MDXH : 3.28 (+2.50%)
ELV : 476.96 (-0.28%)
WGS : 1.5000 (-6.25%)
Why Shares of GeneDx Dropped Wednesday

The potential of a reverse split concerned investors.

WGS : 1.5000 (-6.25%)
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AGL : 11.06 (-0.45%)
WGS : 1.5000 (-6.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 1.7067
2nd Resistance Point 1.6533
1st Resistance Point 1.5767
Last Price 1.5000
1st Support Level 1.4467
2nd Support Level 1.3933
3rd Support Level 1.3167

See More

52-Week High 17.9091
Fibonacci 61.8% 11.5109
Fibonacci 50% 9.5345
Fibonacci 38.2% 7.5582
Last Price 1.5000
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar